Science Explorer Interactive view Map
Company · Ardsley · United States

Acorda Therapeutics (United States)

acorda.comROR OpenAlex
Research works
111
▼ 32% vs 2013–17
Citations
2.5k
22.7 per fractional work
Top-10% rate
13.4%
record average 16.5%
Open access
42%
world 28%

Not ranked overall: Acorda Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 5.87× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 3.29× its world share, 0 worksImmunology and Micro…Neuroscience: 1.30× its world share, 0 worksNeuroscienceChemistry: 0.31× its world share, 0 worksChemistryComputer Science: 0.28× its world share, 0 worksComputer ScienceEnvironmental Science: 0.10× its world share, 0 worksEnvironmental ScienceHealth Professions: 0.59× its world share, 0 worksHealth ProfessionsMedicine: 2.50× its world share, 6 worksMedicineNursing: 7.48× its world share, 0 worksNursingDecision Sciences: 0.76× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.42× its world share, 0 worksEconomics, Econometr…Psychology: 0.32× its world share, 0 worksPsychologySocial Sciences: 0.16× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Nursing, 7.5×. Every wedge is a field page.

Who are the top researchers at Acorda Therapeutics (United States)?

Ranked on the composite score, Andrew R. Blight and Ron Cohen lead among researchers whose main affiliation is Acorda Therapeutics (United States).

  1. 1 Andrew R. Blight United States · #147,032 worldwide 210 citations · 23 works
  2. 2 Ron Cohen United States · #1,384,013 worldwide 13 citations · 35 works
All ranked researchers at Acorda Therapeutics (United States)

Which keywords describe research at Acorda Therapeutics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Diagnostic Criteria, Neurodegeneration, Cognitive Impairment, Multiple Sclerosis, Neuromyelitis Optica, Genetics, Neurological Disorders and Inflammation.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Diagnostic Criteria16▲ 68×5 topics
  2. Neurodegeneration13▲ 37×4 topics
  3. Cognitive Impairment12▲ 46×3 topics
  4. Inflammation11▲ 4.1×23 topics
  5. Multiple Sclerosis11▲ 289×1 topic
  6. Neuromyelitis Optica11▲ 289×1 topic
  7. Genetics9▲ 11×9 topics
  8. Neurological Disorders9▲ 12×11 topics
  9. Epidemiology8▲ 1.89×20 topics
  10. Oxidative Stress8▲ 3.9×18 topics
  11. Parkinson's Disease7▲ 29×4 topics
  12. Clinical Trials6▲ 8.9×9 topics
  13. Ion Channels6▲ 26×2 topics
  14. Spinal Cord Injury6▲ 104×2 topics
  15. Neuroprotection6▲ 15×8 topics
  16. FUS/TLS6▲ 285×1 topic
  17. TDP-436▲ 285×1 topic
  18. Arrhythmias6▲ 38×2 topics
  19. Neuromodulation5▲ 74×2 topics
  20. Treatment5▲ 3.6×8 topics
  21. Mitochondrial Dysfunction5▲ 12×3 topics
  22. Synaptic Plasticity5▲ 14×4 topics
  23. Dopaminergic Neurons5▲ 67×1 topic
  24. Functional Recovery5▲ 34×2 topics
  25. Sudden Cardiac Death5▲ 36×2 topics
  26. a-Synuclein5▲ 86×1 topic
  27. Cytokines4▲ 15×5 topics
  28. Calcium Signaling4▲ 31×2 topics
  29. Cardiac Electrophysiology4▲ 53×1 topic
  30. Long-QT Syndrome4▲ 53×1 topic
  31. Heart Failure4▲ 8.5×6 topics
  32. Neurological Classification4▲ 168×1 topic
  33. Physical Activity4▲ 10×1 topic
  34. Recovery4▲ 41×2 topics
  35. Depression4▲ 4.8×6 topics
  36. Pathogenesis4▲ 5.9×4 topics
  37. Prognosis4▲ 10×4 topics
  38. Brain Development3▲ 16×3 topics
  39. Cell Signaling3▲ 8.9×6 topics
  40. Neuroinflammation3▲ 10×5 topics

Which research topics does Acorda Therapeutics (United States) publish most on?

By volume in 2022–2025: Microtubule and mitosis dynamics, Hippo pathway signaling and YAP/TAZ, Parkinson's Disease Mechanisms and Treatments and Lung Cancer Treatments and Mutations.

Microtubule and mitosis dynamics: 1 fractional worksHippo pathway signaling and YAP/TAZ: 1 fractional worksParkinson's Disease Mechanisms and Treatments: 1 fractional worksLung Cancer Treatments and Mutations: 0 fractional worksTreatment of Major Depression: 0 fractional worksCardiac electrophysiolog…0Cardiac electrophysiology and arrhythmias: 0 fractional worksECG Monitoring and Analysis: 0 fractional worksAtrial Fibrillation Management and Outcomes: 0 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 0 fractional worksCardiac pacing and defibrillation studies: 0 fractional works
Cell BiologyNeurologyPulmonary and Respiratory MedicinePharmacology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Microtubule and mitosis dynamics Cell Biology 1 works
  2. 2 Hippo pathway signaling and YAP/TAZ Cell Biology 1 works
  3. 3 Parkinson's Disease Mechanisms and Treatments Neurology 1 works
  4. 4 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
  5. 5 Treatment of Major Depression Pharmacology 0 works
  6. 6 Cardiac electrophysiology and arrhythmias Cardiology and Cardiovascular Medicine 0 works
  7. 7 ECG Monitoring and Analysis Cardiology and Cardiovascular Medicine 0 works
  8. 8 Atrial Fibrillation Management and Outcomes Cardiology and Cardiovascular Medicine 0 works
  9. 9 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
  10. 10 Cardiac pacing and defibrillation studies Cardiology and Cardiovascular Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available41.8%not open58.2%

World: 28% of research is openly available.

with international co-authors22.1%domestic only77.9%

World: 19% is written across borders.

How has Acorda Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 32% lower than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Ardsley

All research institutions in Ardsley

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.